June 30, 2022
“Our group practice is excited to offer Promaxo. This builds on our commitment to offer state-of-the-art urologic care to treat cancer and improve patient quality of life. As the first practice in Arizona to offer high intensity frequency ultrasound (HIFU) in 2017, and following our recent launch of transurethral ultrasound ablation (TULSA), the Promaxo MRI system now gives us the best determination of cancer location and the ability to do focal therapies for prostate cancer treatment in the convenience of our office,” said Dr. Rahul Mehan, founder of East Valley Urology.
June 21, 2022
The introduction of the Promaxo state-of-the-art technology into our practice will allow for increased accuracy in diagnosing patients with potential lethal prostate cancer within our ambulatory surgery center. Additionally, using this technology will allow us to address the disparity in the use of MRI in patients that are at high-risk for development of prostate cancer, such as African Americans and people of color,” said Dr. James K. Bennett, head of Midtown Urology.
June 8, 2022
Dr. Sandeep Arora, corresponding author for the publication and Assistant Professor of Radiology and Biomedical Imaging at Yale School of Medicine said, "Promaxo's low-field portable MRI technology can potentially reduce MR–US (ultrasound) misregistration errors and be independent of the scheduling pressures of traditional, high field clinical MRI imaging systems."
May 26, 2022
Promaxo, a medical imaging, robotics, and AI technology company, today announced exhibit booth activities showcasing its compact, in-office MRI system at the upcoming American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, IL on June 3-7, 2022. The Annual Meeting is the largest gathering of oncology professionals worldwide.
May 12, 2022
Dr. Prithipal S. Sethi, Head of Urology at Golden State Urology Urology said, “Our practice is rooted in providing comprehensive care to patients, with strong interest in advanced technologies and novel treatments for convenient, optimal care. Adding the Promaxo system into our practice builds upon our principle.
April 28, 2022
“We are pleased to have strategic investors, such as Zepp Health, as we commercialize our truly open MRI system to the broader physician office community,” said Dr. Amit Vohra, Founder and CEO of Promaxo. “Zepp Health’s financial support is a welcome contribution as we execute on our vision and advance MR guided diagnosis and treatment options to our patients and clinical partners.”
